Biosimilar Makers Getting Premium-Linked Inquiries from Medical Institutions

March 13, 2013
Following the recent approval of biosimilars of the recombinant human granulocyte colony stimulating factor (G-CSF) filgrastim (original product name: Gran), some makers are receiving a flurry of inquiries from medical institutions who wish to find out whether the drugs can...read more